Biosimilar Antitrust Pressure On J&J Grows As Walgreen, Kroger Sue Over Remicade Contracts

Pharmacy chains object to J&J agreements with insurers that block coverage of Pfizer and Merck biosimilars except in 'rarest of circumstances'; seek overcharge damages for Remicade purchases.

court house

Walgreen Co. and The Kroger Co. are throwing their weight behind efforts to get a district court to halt Johnson & Johnson's exclusionary contracts that deter the purchase of biosimilars to J&J's Remicade (infliximab).

The two pharmacy chains filed suit against J&J and its subsidiary Janssen Biotech Inc. in the Eastern District of...

More from Biosimilars

More from Biosimilars & Generics